Recall Radar
All recalls › Medicine & devices

Revcovi (elapegademase-lvlr) Injection, 2.4mg/1.5mL (1.6 mg/mL), Single-Dose Vial, Rx Only, For Intramuscular Use Only, Mfd. by Chiesi USA, Inc., Cary, NC 27518, NDC 10122-502-01

Failed Stability Specifications: Out of specification stability result for the protein concentration profile.

Class III Medicine & devices FDA September 9, 2026
Read the official FDA notice →

What to do

Stop using the product and check it against the description above. Follow the remedy on the official notice; most recalls are refunded or replaced without a receipt. If you or a family member has already been affected, keep the packaging and the lot code — they're what a claim rests on later.

Details

Recalling company
Chiesi USA, Inc. — Cary, NC
Severity
Class III — low
Reported
September 9, 2026
Quantity
3,002 vials
Recall number
D-0838-2026
Status
Ongoing
Source
FDA

Where it went

MO, TN

Other medicine & devices recalls

See every current recall on the live dashboard →